The discussion highlights the unprecedented speed at which mRNA vaccines were developed and authorized, raising concerns about bypassed safety protocols. Insights reveal that critical safety studies, including genotoxicity and carcinogenicity, were not conducted, and the rationale behind these omissions is scrutinized. The introduction of novel compounds in the vaccine formulation further complicates the safety narrative, emphasizing the need for thorough examination.
